Lunit Expands AI Medical Imaging Solutions in East & Southea

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced two supply contracts that mark its strategic expansion into the East and Southeast Asian region. Lunit will supply its Lunit INSIGHT CXR for chest abnormality detection and Lunit INSIGHT MMG for mammography analysis to the Chung Shan Medical University in Taiwan and Gleneagles Hospital in Singapore, respectively.

Related Keywords

Seoul , Soult Ukpyolsi , South Korea , Chung Shan , T Ai Chung , Taiwan , Gleneagles Hospital , Singapore General , Singapore , Brandon Suh , Chung Shan Medical University , Chung Shan Medical University To Pioneer , Lancet Digital Health , Lung Cancer , Hospital Singapore Chooses Lunit , Enhanced Breast Cancer , Southeast Asia , Singapore Quality Class , Gleneagles Hospital Singapore , Clinical Oncology , Lung Cancer Screening , I Company , Unit , Lunit Insight , Southeast Asian Region , Cancer Screening ,